1-Ethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

Catalog No. :
ACWXBF362
CAS No. :
874291-00-6
Molecular Formula :
C15H23BN2O3
Molecular Weight :
290.17

IUPAC Name:1-ethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea

1-Ethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$194.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Ethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea
IUPAC Name1-ethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea
MDL No.MFCD08689523
Molecular FormulaC15H23BN2O3
Molecular Weight290.17
SMILESO=C(NC1=CC=C(B2OC(C)(C)C(C)(C)O2)C=C1)NCC
InChI KeyBYHDTZHNPIWVOP-UHFFFAOYSA-N
SynonymDTXSID10657185 | FT-0688855 | J-504601 | 4-[(ETHYLCARBAMOYL)AMINO]BENZENEBORONIC ACID, PINACOL ESTER 98%4-(3-ETHYLUREIDO)BENZENEBORONIC ACID, PINACOL ESTER | 1-Ethyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]urea | 4-(3-Ethylureido)benzeneb
CAS No.874291-00-6
PubChem CID44119377

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACWXBF362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACJPCW450 route compound structure diagram
    ACJPCW45082745-18-4 In Stock
  4. Then
  5. ACWXBF362 route product structure diagram
    ACWXBF362874291-00-6
Inquiry

2. ACWXBF362 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJPCW450 route compound structure diagram
    ACJPCW45082745-18-4 In Stock
  2. Then
  3. ACWXBF362 route product structure diagram
    ACWXBF362874291-00-6
Inquiry

Comments (0)